Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories is the leading Indian company manufacturing pharmaceuticals and Active Pharmaceutical Ingredients, now in the process of becoming a research-driven global pharmaceutical company. Seeks partners for in and out licensing of technologies. Technological capabilities position to offer unique opportunities to technology oriented companies. Identified the OTC as a potential segment for fueling growth: Has in-licensed the following products for the Indian market: - Sparfloxacin (Dainippon-Japan) - Benedipine (Kyowa Hakko-Japan) In R&D our basic research is in the areas of: Antiinfectives, Cardiovascular, Anticancer. Ranbaxy acquired Bayer's Generics Business in Germany. Ranbaxy will trade in Germany under the name, Basics GmbH, as its wholly owned subsidiary in Germany. The current business portfolio includes 20 marketed generic products with all their formulations. Ranbaxy will progressively expand the portfolio through addition of its own products.

Activity:

- Licensing & Business Development
- Manufacturing

Product / Technology type(s) covered:

- Generics
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe , North America , Asia , Africa , South America , Near/Middle East

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: